Stay updated on Pembrolizumab for Leptomeningeal Disease Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Leptomeningeal Disease Clinical Trial page.

Latest updates to the Pembrolizumab for Leptomeningeal Disease Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedNew navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status message 'No longer looking for participants' now appears on the page. The label for Intervention/Treatment was standardized, and the revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.6%

- Check15 days agoChange DetectedThe ClinicalTrials.gov entry version was updated from v3.5.4 to v3.5.5, indicating a new revision of the study record. This reflects a version update, typically for minor edits or corrections, not a change to study design or outcomes.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page's revision entry now shows Revision: v3.5.4 as the current version, replacing the previous Revision: v3.5.3.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page now shows Revision: v3.5.3 replacing Revision: v3.5.2, indicating a small update to the page's release labeling.SummaryDifference0.1%

- Check65 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2; no visible study content changes.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Leptomeningeal Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Leptomeningeal Disease Clinical Trial page.